Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Iranian boy with intellectual disability
- PMID:37467311
- DOI: 10.1093/labmed/lmad064
Molecular and phenotypical findings of a novel de novo SYNGAP1 gene variant in an 11-year-old Iranian boy with intellectual disability
Abstract
Objective: Intellectual developmental disorder (IDD) type 5 is an autosomal dominant (AD) disorder and is characterized by intellectual disability (ID), psychomotor developmental delay, variable autism phenotypes, microcephaly, and seizure. IDD can be caused by mutations in the SYNGAP1 gene, which encodes a Ras GTPase-activating protein. This study revealed a novel de novo nonsense variant in SYNGAP1. The identification of such variants is essential for genetic counseling in patients and their families.
Methods: Exome sequencing implicated the causative variant. Sanger sequencing and cosegregation analyses were used to confirm the variant. Multiple in silico analysis tools were applied to interpret the variant using the American College of Medical Genetics and Genomics and the Association for Molecular Pathology guidelines.
Results: The de novo NM_006772.3(SYNGAP1):c.3685C>T variant was identified in an 11-year-old boy with severe intellectual disability, neurodevelopmental delay, speech disorder, ataxia, specific dysmorphic facial features, and aggressive behavior.
Conclusion: The current study findings expand the existing knowledge of variants in SYNGAP1 that have been previously associated with nonsyndromic intellectual disability and autism, extending the spectrum of phenotypes associated with this gene. The data have implications for genetic diagnosis and counseling in similar phenotypic presentations.
Keywords: IDD; Iran; MRD; SYNGAP1; ataxia; de novo; developmental delay; intellectual disability.
© The Author(s) 2023. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
- Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.Prchalova D, Havlovicova M, Sterbova K, Stranecky V, Hancarova M, Sedlacek Z.Prchalova D, et al.BMC Med Genet. 2017 Jun 2;18(1):62. doi: 10.1186/s12881-017-0425-4.BMC Med Genet. 2017.PMID:28576131Free PMC article.
- Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms.Kimura Y, Akahira-Azuma M, Harada N, Enomoto Y, Tsurusaki Y, Kurosawa K.Kimura Y, et al.Congenit Anom (Kyoto). 2018 Nov;58(6):188-190. doi: 10.1111/cga.12273. Epub 2018 Feb 13.Congenit Anom (Kyoto). 2018.PMID:29381230Review.
- Novel Mutation of SYNGAP1 Associated with Autosomal Dominant Mental Retardation 5 in a Chinese Patient.Pei Y, Li W, Du L, Wei F.Pei Y, et al.Fetal Pediatr Pathol. 2018 Dec;37(6):400-403. doi: 10.1080/15513815.2018.1497113. Epub 2018 Dec 21.Fetal Pediatr Pathol. 2018.PMID:30572772
- Identification of an individual with a SYGNAP1 pathogenic mutation in India.Verma V, Mandora A, Botre A, Clement JP.Verma V, et al.Mol Biol Rep. 2020 Nov;47(11):9225-9234. doi: 10.1007/s11033-020-05915-4. Epub 2020 Oct 22.Mol Biol Rep. 2020.PMID:33090308
- SYNGAP1 mutations: Clinical, genetic, and pathophysiological features.Agarwal M, Johnston MV, Stafstrom CE.Agarwal M, et al.Int J Dev Neurosci. 2019 Nov;78:65-76. doi: 10.1016/j.ijdevneu.2019.08.003. Epub 2019 Aug 24.Int J Dev Neurosci. 2019.PMID:31454529Review.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources